| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine (NCT05371353) | Shanghai Bovax Biotechnology Co., Ltd. | 2022-05-14 |
| Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years (NCT05027776) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-09-15 |
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine (NCT03900572) | Shanghai Zerun Biotechnology Co.,Ltd | 2019-03-09 |
| A Phase I Study of Quadrivalent HPV Recombinant Vaccine (NCT03085381) | Shanghai Bovax Biotechnology Co., Ltd. | 2016-12-01 |
| Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China (NCT01021904) | Chinese Academy of Medical Sciences | 2010-06-01 |
| Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191 (NCT01086709) | National Cancer Institute (NCI) | 2010-01-27 |
| Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population (NCT00847340) | La Fundacion para la Investigacion y el Desarrollo | 2009-12-01 |
| Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034) (NCT00733122) | Merck Sharp & Dohme LLC | 2009-10-01 |
| Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls (NCT00956553) | Public Health England | 2009-09-01 |
| A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) (NCT00943722) | Merck Sharp & Dohme LLC | 2009-08-27 |
| Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) (NCT00834106) | Merck Sharp & Dohme LLC | 2008-12-31 |
| Significance of the High-risk Hpv Viral Load (NCT00682812) | Assistance Publique Hopitaux De Marseille | 2008-06-16 |
| An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) (NCT00635830) | Merck Sharp & Dohme LLC | 2008-03-01 |
| A Study to Identify Markers in Blood and Tissue of HPV Clearance (NCT00711815) | University of Alabama at Birmingham | 2007-01-01 |
| V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) (NCT00411749) | Merck Sharp & Dohme LLC | 2006-12-11 |